Cover Image
市場調查報告書

乾癬治療藥的全球市場 (2016-2024年):各產品 (TNF抑制劑、維他命D類比&並用劑、白細胞介素受體阻斷劑)、治療區分、銷售管道的產業分析、市場趨勢分析、市場規模及市場佔有率的預測

Psoriasis Treatment Market (Product - TNF Inhibitors, Vitamin D Analogues or Combinations, and Interleukin Blockers; Therapy; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

出版商 Transparency Market Research 商品編碼 422942
出版日期 內容資訊 英文 178 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
乾癬治療藥的全球市場 (2016-2024年):各產品 (TNF抑制劑、維他命D類比&並用劑、白細胞介素受體阻斷劑)、治療區分、銷售管道的產業分析、市場趨勢分析、市場規模及市場佔有率的預測 Psoriasis Treatment Market (Product - TNF Inhibitors, Vitamin D Analogues or Combinations, and Interleukin Blockers; Therapy; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日期: 2017年01月06日 內容資訊: 英文 178 Pages
簡介

本報告提供全球乾癬治療藥的市場調查,市場及產品概要,產業趨勢,供需方案,市場成長的各種影響因素與市場機會分析,各產品類型、治療區分、通路、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,市場佔有率,以及主要企業的簡介等彙整。

第1章 序章

第2章 前提條件、調查手法

第3章 摘要整理

  • 全球市場概要
  • 市場佔有率分析:各地區
  • 市場機會藍圖

第4章 市場概要

  • 產品概要
  • 產業上主要事件
  • 市場規模的變化與預測
  • 市場展望
  • 供需方案
  • 波特分析

第5章 市場動態

  • 成長推動因素
  • 阻礙成長要素
  • 市場機會
  • 主要趨勢

第6章 市場分析:各產品類型

  • 主要調查結果
  • 簡介
  • 市場佔有率分析:各產品類型
  • 市場分析:各產品類型
    • TN 抑制劑
    • 維他命D類比、並用劑
    • 白細胞介素受體阻斷劑
    • 其他
  • 市場魅力相關分析:各產品類型
  • 主要趨勢

第7章 市場分析:各治療種類

  • 主要調查結果
  • 簡介
  • 市場佔有率分析:各治療種類
  • 市場分析:各治療種類
    • 局部治療藥
    • 全身性治療藥
    • 並用劑、其他
  • 市場魅力相關分析:各治療種類
  • 主要趨勢

第8章 市場分析:各銷售管道

  • 主要調查結果
  • 簡介
  • 市場佔有率分析:各銷售管道
  • 市場分析:各銷售管道
    • 院內藥局
    • 零售藥局
    • 線上銷售
  • 市場魅力相關分析:各銷售管道
  • 主要趨勢

第9章 市場分析:各地區

  • 市場概要:各國
  • 市場佔有率分析:各地區
  • 市場預測:各地區
  • 市場魅力相關分析:各地區

第10章 北美市場

  • 主要調查結果
  • 市場概要
  • 市場佔有率分析:各產品
  • 市場預測:各產品
  • 市場佔有率分析:各治療種類
  • 市場預測:各治療種類
  • 市場佔有率分析:各銷售管道
  • 市場預測:各銷售管道
  • 市場分析:各國
  • 市場佔有率分析:各國
  • 市場規模預測:各國
  • 美國
  • 加拿大
  • 市場魅力相關分析
  • 市場趨勢

第11章 歐洲市場

  • 主要調查結果
  • 市場概要
  • 市場佔有率分析:各產品
  • 市場預測:各產品
  • 市場佔有率分析:各治療種類
  • 市場預測:各治療種類
  • 市場佔有率分析:各銷售管道
  • 市場預測:各銷售管道
  • 市場分析:各國
  • 市場佔有率分析:各國
  • 市場規模預測:各國
  • 德國
  • 英國
  • 西班牙
  • 義大利
  • 法國
  • 其他
  • 市場魅力相關分析
  • 市場趨勢

第12章 亞太地區市場

  • 主要調查結果
  • 市場概要
  • 市場佔有率分析:各產品
  • 市場預測:各產品
  • 市場佔有率分析:各治療種類
  • 市場預測:各治療種類
  • 市場佔有率分析:各銷售管道
  • 市場預測:各銷售管道
  • 市場分析:各國
  • 市場佔有率分析:各國
  • 市場規模預測:各國
  • 日本
  • 中國
  • 澳洲&紐西蘭
  • 印度
  • 其他
  • 市場魅力相關分析
  • 市場趨勢

第13章 南美市場

  • 主要調查結果
  • 市場概要
  • 市場佔有率分析:各產品
  • 市場預測:各產品
  • 市場佔有率分析:各治療種類
  • 市場預測:各治療種類
  • 市場佔有率分析:各銷售管道
  • 市場預測:各銷售管道
  • 市場分析:各國
  • 市場佔有率分析:各國
  • 市場規模預測:各國
  • 巴西
  • 墨西哥
  • 其他
  • 市場魅力相關分析
  • 市場趨勢

第14章 中東、非洲市場

  • 主要調查結果
  • 市場概要
  • 市場佔有率分析:各產品
  • 市場預測:各產品
  • 市場佔有率分析:各治療種類
  • 市場預測:各治療種類
  • 市場佔有率分析:各銷售管道
  • 市場預測:各銷售管道
  • 市場分析:各國
  • 市場佔有率分析:各國
  • 市場規模預測:各國
  • 南非
  • 沙烏地阿拉伯
  • 其他
  • 市場魅力相關分析
  • 市場趨勢

第15章 企業簡介

  • 企業的市場佔有率分析
  • 競爭矩陣
  • 企業簡介
    • Amgen, Inc.
    • Eli Lilly & Company
    • Novartis AG
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Pfizer, Inc.
    • AstraZeneca
    • AbbVie, Inc.
    • LEO Pharma A/S
    • Biogen

圖表

目錄

Title: Psoriasis Treatment Market (Product - TNF Inhibitors, Vitamin D Analogues or Combinations, and Interleukin Blockers; Therapy - Topical Therapeutic Drugs, Systemic Therapeutic Drugs, and Combinations; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Psoriasis Treatment Market - Overview

This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline drugs are some of the factors expected to drive the growth of global Psoriasis Treatment market during the forecast period.

The Psoriasis Treatment market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on products, distribution channel, therapy type and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section.

Additionally, the section comprises Porter's Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global Psoriasis Treatment market.

Global Psoriasis Treatment Market - Segmentation

In this report, the market segments have been analyzed based on availability of approved products, cost-effectiveness, and preference for technological systems by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on product type, the market has been segmented into TNF Inhibitors, Vitamin D analogues or its combination, Interleukin Blockers and Others. Interleukin blockers segment is likely to be the most attractive segment in the near future due to its increasing use and its ability to act selectively by targeting the proteins. The segment is expected to grow at a highest CAGR rate during forecast period.

Based on Therapy type, the global Psoriasis Treatment market has been segmented into Topical Therapeutic Drugs, Systemic Therapeutic Drugs, Combinations of therapies & others. The market segments have been extensively analyzed based on increase in demand for the therapies, availability of the drug products, and cost of therapy and severity of the disease.

Different types of distribution channels are responsible for making the psoriasis treatment available in the market. The distribution channels are Hospital pharmacy, Retail pharmacy and the online sales. Under the distribution channel segment, hospital pharmacy plays a major role followed by retail pharmacy and online sales.

Geographically, the global Psoriasis Treatment market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa).

Companies Mentioned in the Report

The report also profiles major players in the global Psoriasis Treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Amgen Inc., Eli Lilly and Company, Novartis AG, Merck & Co., Inc., Johnson & Johnson, Pfizer, Inc., AstraZeneca, AbbVie Inc., LEO Pharma A/S and Biogen.

The Global Psoriasis Treatment Market has been segmented as given below:

Psoriasis Treatment Market, by Product

  • TNF Inhibitors
  • Vitamin D Analogues or Combinations
  • Interleukin Blockers
  • Others

Psoriasis Treatment Market, by Therapy

  • Topical Therapeutic Drugs
  • Systemic Therapeutic Drugs
  • Combinations
  • Others

Psoriasis Treatment Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Others

Psoriasis Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Psoriasis Treatment Market Snapshot
  • 3.2. Market Share Analysis by Region, 2015
  • 3.3. Global Psoriasis Treatment Market : Opportunity Map

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Global Psoriasis Treatment Market : Key Industry Events
  • 4.3. Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2014-2024
  • 4.4. Psoriasis Treatment Market Outlook
  • 4.5. Global Psoriasis Treatment Supply Demand Scenario
  • 4.6. Porter's Analysis

5. Market Dynamics

  • 5.1. Drivers
    • 5.1.1. Approval of new biologics
    • 5.1.2. Increase in access for treatment in developing markets
    • 5.1.3. Novel Pipeline Drugs
    • 5.1.4. Increase in the number of psoriasis patients
  • 5.2. Restrains
    • 5.2.1. Loss of response to current therapies
    • 5.2.2. Premium-priced biologics
  • 5.3. Opportunities
    • 5.3.1. Newer modalities and availability of predictive biomarkers, offer opportunity of personalized treatment for psoriasis
    • 5.3.2. Specialty biologics set to lose their exclusivity status
  • 5.4. Key Trends
    • 5.4.1. Increasing cost of psoriasis biologics
    • 5.4.2. The number of physicians that practice independently has been declining

6. Psoriasis Treatment Market Analysis, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Psoriasis Treatment Market Value Share Analysis, by Product Type
  • 6.4. Psoriasis Treatment Market Analysis, by Product Type
    • 6.4.1. TNF Inhibitors
    • 6.4.2. Vitamin D Analogues or Combinations
    • 6.4.3. Interleukin Blockers
    • 6.4.4. Others
  • 6.5. Psoriasis Treatment Market Attractiveness Analysis, by Product Type
  • 6.6. Key Trends

7. Psoriasis Treatment Market Analysis, by Therapy

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Global Psoriasis Treatment Market Value Share Analysis, by Therapy
  • 7.4. Psoriasis Treatment Market Analysis, by Therapy
    • 7.4.1. Topical Therapeutic Drugs
    • 7.4.2. Systemic Therapeutic Drugs
    • 7.4.3. Combinations & Others
  • 7.5. Psoriasis Treatment Market Attractiveness Analysis, by Therapy
  • 7.6. Key Trends

8. Psoriasis Treatment Market Analysis, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
  • 8.3. Global Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
  • 8.4. Psoriasis Treatment Market Analysis, by Distribution Channel
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Sales
  • 8.5. Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
  • 8.6. Key Trends

9. Psoriasis Treatment Market Analysis, by Region

  • 9.1. Global Psoriasis Treatment Market Snapshot, by Country
  • 9.2. Global Psoriasis Treatment Market Value Share Analysis, by Region
  • 9.3. Psoriasis Treatment Market Forecast, by Region
  • 9.4. Psoriasis Treatment Market Attractiveness Analysis, by Region

10. North America Psoriasis Treatment Market Analysis

  • 10.1. Key Findings
  • 10.2. North America Psoriasis Treatment Market Overview
  • 10.3. North America Market Value Share Analysis, by Product
  • 10.4. North America Market Forecast, by Product
    • 10.4.1. TNF Inhibitors
    • 10.4.2. Vitamin D Analogues or Combinations
    • 10.4.3. Interleukin Blockers
    • 10.4.4. Others
  • 10.5. North America Market Value Share Analysis, by Therapy
  • 10.6. North America Market Forecast, by Therapy
    • 10.6.1. Topical Therapeutic Drugs
    • 10.6.2. Systemic Therapeutic Drugs
    • 10.6.3. Combinations & Others
  • 10.7. North America Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
  • 10.8. North America Market Forecast, by Distribution Channel
    • 10.8.1. Hospital Pharmacy
    • 10.8.2. Retail Pharmacy
    • 10.8.3. Online Sales
  • 10.9. Market Analysis, by Country
  • 10.10. Market Value Share Analysis, by Country
  • 10.11. Market Size (US$ Mn) Forecast, by Country, 2016-2024
    • 10.11.1. U.S.
    • 10.11.2. Canada
  • 10.12. Market Attractiveness Analysis
    • 10.12.1. By Product
    • 10.12.2. By Therapy
    • 10.12.3. By Distribution Channel
    • 10.12.4. By Country
  • 10.13. Market Trends

11. Europe Psoriasis Treatment Market Analysis

  • 11.1. Key Findings
  • 11.2. Europe Psoriasis Treatment Market Overview
  • 11.3. Europe Market Value Share Analysis, by Product
  • 11.4. Europe Market Forecast, by Product
    • 11.4.1. TNF Inhibitors
    • 11.4.2. Vitamin D Analogues or Combinations
    • 11.4.3. Interleukin Blockers
    • 11.4.4. Others
  • 11.5. Europe Market Value Share Analysis, by Therapy
  • 11.6. Europe Market Forecast, by Therapy
    • 11.6.1. Topical Therapeutic Drugs
    • 11.6.2. Systemic Therapeutic Drugs
    • 11.6.3. Combinations & Others
  • 11.7. Europe Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
  • 11.8. Europe Market Forecast, by Distribution Channel
    • 11.8.1. Hospital Pharmacy
    • 11.8.2. Retail Pharmacy
    • 11.8.3. Online Sales
  • 11.9. Market Analysis, by Country
  • 11.10. Market Value Share Analysis, by Country
  • 11.11. Market Size (US$ Mn) Forecast, by Country, 2016-2024
    • 11.11.1. Germany
    • 11.11.2. U.K.
    • 11.11.3. Spain
    • 11.11.4. Italy
    • 11.11.5. France
    • 11.11.6. Rest of Europe
  • 11.12. Market Attractiveness Analysis
    • 11.12.1. By Product
    • 11.12.2. By Therapy
    • 11.12.3. By Distribution Channel
    • 11.12.4. By Country
  • 11.13. Market Trends

12. Asia Pacific Psoriasis Treatment Market Analysis

  • 12.1. Key Findings
  • 12.2. Asia Pacific Psoriasis Treatment Market Overview
  • 12.3. Asia Pacific Market Value Share Analysis, by Product
  • 12.4. Asia Pacific Market Forecast, by Product
    • 12.4.1. TNF Inhibitors
    • 12.4.2. Vitamin D Analogues or Combinations
    • 12.4.3. Interleukin Blockers
    • 12.4.4. Others
  • 12.5. Asia Pacific Market Value Share Analysis, by Therapy
  • 12.6. Asia Pacific Market Forecast, by Therapy
    • 12.6.1. Topical Therapeutic Drugs
    • 12.6.2. Systemic Therapeutic Drugs
    • 12.6.3. Combinations & Others
  • 12.7. Asia Pacific Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
  • 12.8. Asia Pacific Market Forecast, by Distribution Channel
    • 12.8.1. Hospital Pharmacy
    • 12.8.2. Retail Pharmacy
    • 12.8.3. Online Sales
  • 12.9. Market Analysis, by Country
  • 12.10. Market Value Share Analysis, by Country
  • 12.11. Market Size (US$ Mn) Forecast, by Country, 2016-2024
    • 12.11.1. Japan
    • 12.11.2. China
    • 12.11.3. Australia & New Zealand
    • 12.11.4. India
    • 12.11.5. Rest of Asia Pacific
  • 12.12. Market Attractiveness Analysis
    • 12.12.1. By Product
    • 12.12.2. By Therapy
    • 12.12.3. By Distribution Channel
    • 12.12.4. By Country
  • 12.13. Market Trends

13. Latin America Psoriasis Treatment Market Analysis

  • 13.1. Key Findings
  • 13.2. Latin America Psoriasis Treatment Market Overview
  • 13.3. Latin America Market Value Share Analysis, by Product
  • 13.4. Latin America Market Forecast, by Product
    • 13.4.1. TNF Inhibitors
    • 13.4.2. Vitamin D Analogues or Combinations
    • 13.4.3. Interleukin Blockers
    • 13.4.4. Others
  • 13.5. Latin America Market Value Share Analysis, by Therapy
  • 13.6. Latin America Market Forecast, by Therapy
    • 13.6.1. Topical Therapeutic Drugs
    • 13.6.2. Systemic Therapeutic Drugs
    • 13.6.3. Combinations & Others
  • 13.7. Latin America Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
  • 13.8. Latin America Market Forecast, by Distribution Channel
    • 13.8.1. Hospital Pharmacy
    • 13.8.2. Retail Pharmacy
    • 13.8.3. Online Sales
  • 13.9. Market Analysis, by Country
  • 13.10. Market Value Share Analysis, by Country
  • 13.11. Market Size (US$ Mn) Forecast, by Country, 2016-2024
    • 13.11.1. Brazil
    • 13.11.2. Mexico
    • 13.11.3. Rest of Latin America
  • 13.12. Market Attractiveness Analysis
    • 13.12.1. By Product
    • 13.12.2. By Therapy
    • 13.12.3. By Distribution Channel
    • 13.12.4. By Country
  • 13.13. Market Trends

14. Middle East & Africa Psoriasis Treatment Market Analysis

  • 14.1. Key Findings
  • 14.2. Middle East & Africa Psoriasis Treatment Market Overview
  • 14.3. Middle East & Africa Market Value Share Analysis, by Product
  • 14.4. Middle East & Africa Market Forecast, by Product
    • 14.4.1. TNF Inhibitors
    • 14.4.2. Vitamin D Analogues or Combinations
    • 14.4.3. Interleukin Blockers
    • 14.4.4. Others
  • 14.5. Middle East & Africa Market Value Share Analysis, by Therapy
  • 14.6. Middle East & Africa Market Forecast, by Therapy
    • 14.6.1. Topical Therapeutic Drugs
    • 14.6.2. Systemic Therapeutic Drugs
    • 14.6.3. Combinations & Others
  • 14.7. Middle East & Africa Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
  • 14.8. Middle East & Africa Market Forecast, by Distribution Channel
    • 14.8.1. Hospital Pharmacy
    • 14.8.2. Retail Pharmacy
    • 14.8.3. Online Sales
  • 14.9. Market Analysis, by Country
  • 14.10. Market Value Share Analysis, by Country
  • 14.11. Market Size (US$ Mn) Forecast, by Country, 2016-2024
    • 14.11.1. South Africa
    • 14.11.2. Saudi Arabia
    • 14.11.3. Rest of Middle East & Africa
  • 14.12. Market Attractiveness Analysis
    • 14.12.1. By Product
    • 14.12.2. By Therapy
    • 14.12.3. By Distribution Channel
    • 14.12.4. By Country
  • 14.13. Market Trends

15. Company Profiles

  • 15.1. Psoriasis Treatment Market Share Analysis, by Company (2015)
  • 15.2. Competition Matrix
  • 15.3. Company Profiles
    • 15.3.1. Amgen, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Eli Lilly & Company
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Novartis AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Merck & Co., Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Johnson & Johnson
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Pfizer, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. AstraZeneca
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. AbbVie, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. LEO Pharma A/S
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Biogen
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Figures

  • Figure 1: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 2: Global Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
  • Figure 3: Global TNF Inhibitors Market Revenue (US$ Mn),
  • Figure 4: Global Vitamin D Analogues or Combinations Market Revenue (US$ Mn), 2014-2024
  • Figure 5: Global Interleukin Blockers Market Revenue (US$ Mn), 2014-2024
  • Figure 6: Global Others Market Revenue (US$ Mn), 2014-2024
  • Figure 7: Psoriasis Treatment Market Attractiveness Analysis, by Product Type, 2016-2024
  • Figure 8: Global Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
  • Figure 9: Global Topical Therapeutic Drugs Market Revenue (US$ Mn), 2014-2024
  • Figure 10: Global Systemic Therapeutic Drugs Market Revenue (US$ Mn), 2014-2024
  • Figure 11: Global Combinations & Others Market Revenue (US$ Mn), 2014-2024
  • Figure 12: Psoriasis Treatment Market Attractiveness Analysis, by Therapy, 2016-2024
  • Figure 13: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 14: Global Hospital Pharmacy Market Revenue (US$ Mn), 2014-2024
  • Figure 15: Global Retail Pharmacy Market Revenue (US$ Mn), 2014-2024
  • Figure 16: Global Online Sales Market Revenue (US$ Mn), 2014-2024
  • Figure 17: Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2016-2024
  • Figure 18: Global Psoriasis Treatment Market Value Share, by Region, 2016 and 2024
  • Figure 19: Psoriasis Treatment Market Attractiveness Analysis, by Region, 2016-2024
  • Figure 20: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 21: North America Market Attractiveness Analysis,
  • Figure 22: North America Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
  • Figure 23: North America Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
  • Figure 24: North America Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 25: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 26: North America Psoriasis Treatment Market Attractiveness Analysis, by Product
  • Figure 27: North America Psoriasis Treatment Market Attractiveness Analysis, by Therapy
  • Figure 28: North America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
  • Figure 29: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 30: Europe Market Attractiveness Analysis,
  • Figure 31: Europe Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
  • Figure 32: Europe Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
  • Figure 33: Europe Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 34: Europe Psoriasis Treatment Market Value Share, by Country, 2016 and 2024
  • Figure 35: Europe Psoriasis Treatment Market Attractiveness Analysis, by Product
  • Figure 36: Europe Psoriasis Treatment Market Attractiveness Analysis, by Therapy
  • Figure 37: Europe Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
  • Figure 38: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 39: Asia Pacific Market Attractiveness Analysis,
  • Figure 40: Asia Pacific Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
  • Figure 41: Asia Pacific Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
  • Figure 42: Asia Pacific Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 43: Asia Pacific Psoriasis Treatment Market Value Share, by Country, 2016 and 2024
  • Figure 44: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Product
  • Figure 45: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Therapy
  • Figure 46: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
  • Figure 47: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 48: Latin America Market Attractiveness Analysis,
  • Figure 49: Latin America Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
  • Figure 50: Latin America Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
  • Figure 51: Latin America Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 52: Latin America Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 53: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Product
  • Figure 54: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Therapy
  • Figure 55: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
  • Figure 56: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 57: Middle East & Africa Market Attractiveness Analysis,
  • Figure 58: Middle East & Africa Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
  • Figure 59: Middle East & Africa Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
  • Figure 60: Middle East & Africa Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 61: Middle East & Africa Market Value Share, by Country, 2016 and 2024
  • Figure 62: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Product
  • Figure 63: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Therapy
  • Figure 64: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
  • Figure 65: Global Psoriasis Treatment Market Share Analysis, by Company (2015)

List of Tables

  • Table 1: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • Table 2: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014-2024
  • Table 3: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 4: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Region, 2014-2024
  • Table 5: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • Table 6: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014-2024
  • Table 7: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 8: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 9: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • Table 10: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014-2024
  • Table 11: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 12: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 13: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • Table 14: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014-2024
  • Table 15: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 16: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 17: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • Table 18: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014-2024
  • Table 19: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 20: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 21: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • Table 22: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014-2024
  • Table 23: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 24: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014-2024
Back to Top